Variant report

Variant	nsv547567
Chromosome Location	chr1:113313563-113384015
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:52)
LncRNA
region (count:31)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:52 , 50 per page) page: 1 2

No.	Distal block	Cell Line	Cell type
1	chr1:113270002..113271018-chr1:113346519..113347901,8	MCF-7	breast:
2	chr1:113311989..113313843-chr1:113322211..113324163,2	K562	blood:
3	chr1:113361966..113363872-chr1:113371616..113374347,2	K562	blood:
4	chr1:113260737..113262292-chr1:113346514..113347895,8	MCF-7	breast:
5	chr1:113332030..113332946-chr20:56000234..56001227,2	MCF-7	breast:
6	chr1:113261041..113262045-chr1:113346518..113347739,14	MCF-7	breast:
7	chr1:113379016..113381976-chr1:113384140..113386902,2	MCF-7	breast:
8	chr1:113257560..113260668-chr1:113344360..113350242,8	MCF-7	breast:
9	chr1:113258243..113259603-chr1:113346569..113347471,7	MCF-7	breast:
10	chr1:113351562..113352325-chr1:113615161..113616117,3	MCF-7	breast:
11	chr1:113342047..113343911-chr1:113444698..113447399,2	K562	blood:
12	chr1:113382661..113385204-chr1:113393197..113394858,2	MCF-7	breast:
13	chr1:113314765..113317028-chr1:113318747..113320403,2	K562	blood:
14	chr1:113360437..113362050-chr1:113412669..113415625,2	K562	blood:
15	chr1:113258681..113259438-chr1:113351567..113352234,2	MCF-7	breast:
16	chr1:113346446..113346980-chr21:29107601..29108558,2	MCF-7	breast:
17	chr1:113259850..113261663-chr1:113346224..113348160,2	K562	blood:
18	chr1:113334172..113336073-chr1:113497072..113498817,2	K562	blood:
19	chr1:113351564..113352512-chr1:113584963..113585860,4	MCF-7	breast:
20	chr1:113261035..113261874-chr1:113348328..113348915,2	MCF-7	breast:
21	chr1:113346242..113347922-chr1:113394008..113395856,2	MCF-7	breast:
22	chr1:113254388..113257087-chr1:113348498..113350329,2	MCF-7	breast:
23	chr1:113258153..113259710-chr1:113345919..113347682,21	MCF-7	breast:
24	chr1:113256920..113257653-chr1:113351799..113352468,2	MCF-7	breast:
25	chr1:113258859..113259494-chr1:113351565..113352185,2	MCF-7	breast:
26	chr1:113314765..113317028-chr1:113318747..113320403,2	K562	blood:
27	chr1:113350162..113352262-chr1:113614646..113616271,2	MCF-7	breast:
28	chr1:113279985..113280850-chr1:113346538..113347427,2	K562	blood:
29	chr1:113269314..113271900-chr1:113344894..113347076,3	MCF-7	breast:
30	chr1:113361966..113363872-chr1:113371616..113374347,2	K562	blood:
31	chr1:113336004..113338638-chr1:113347220..113350748,3	K562	blood:
32	chr1:113257528..113259830-chr1:113345553..113348526,2	K562	blood:
33	chr1:113351744..113352435-chr1:113615333..113616324,3	K562	blood:
34	chr1:113337235..113339219-chr1:113339220..113340915,2	MCF-7	breast:
35	chr1:113336004..113338638-chr1:113347220..113350748,3	K562	blood:
36	chr1:113383663..113385223-chr1:113386866..113389078,2	MCF-7	breast:
37	chr1:113337235..113339219-chr1:113339220..113340915,2	MCF-7	breast:
38	chr1:113258353..113266082-chr1:113344715..113349789,9	MCF-7	breast:
39	chr1:113262194..113266688-chr1:113347880..113352224,5	MCF-7	breast:
40	chr1:113280037..113281182-chr1:113346502..113347495,4	MCF-7	breast:
41	chr1:113258018..113259770-chr1:113346059..113348138,22	K562	blood:
42	chr1:113351576..113352442-chr1:113423249..113424028,4	MCF-7	breast:
43	chr1:113351549..113352456-chr1:113584930..113585890,3	K562	blood:
44	chr1:113260993..113261954-chr1:113346492..113347443,7	K562	blood:
45	chr1:113351443..113352326-chr1:113584981..113585924,5	MCF-7	breast:
46	chr1:113311989..113313843-chr1:113322211..113324163,2	K562	blood:
47	chr1:113286977..113288523-chr1:113338925..113341550,2	K562	blood:
48	chr1:113256377..113259219-chr1:113330074..113333920,3	MCF-7	breast:
49	chr1:113331242..113332912-chr1:113335050..113337529,2	MCF-7	breast:
50	chr1:113331242..113332912-chr1:113335050..113337529,2	MCF-7	breast:

(count:31 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-SLC16A1-1	chr1:113366275-113366435	NONHSAT005282
2	lnc-SLC16A1-1	chr1:113368135-113368294	XLOC_000966
3	lnc-SLC16A1-1	chr1:113383110-113383202	XLOC_000966
4	lnc-SLC16A1-1	chr1:113368135-113368294	XLOC_000966
5	lnc-SLC16A1-1	chr1:113383110-113383202	ENSG00000215866.3
6	lnc-SLC16A1-1	chr1:113366275-113366376	XLOC_000966
7	lnc-SLC16A1-1	chr1:113366275-113366376	XLOC_000966
8	lnc-FAM19A3-5	chr1:113362647-113363601	NONHSAT005283
9	lnc-SLC16A1-1	chr1:113362635-113363163	NONHSAT005282
10	lnc-SLC16A1-1	chr1:113368059-113368541	NONHSAT005282
11	lnc-SLC16A1-1	chr1:113366275-113366376	ENSG00000215866.3
12	lnc-SLC16A1-1	chr1:113371099-113371133	NONHSAT005284
13	lnc-SLC16A1-1	chr1:113366275-113366376	XLOC_000966
14	lnc-SLC16A1-1	chr1:113362912-113363160	XLOC_000966
15	lnc-SLC16A1-1	chr1:113383110-113383202	NONHSAT005284
16	lnc-SLC16A1-1	chr1:113362792-113363160	XLOC_000966
17	lnc-SLC16A1-1	chr1:113368135-113368380	XLOC_000966
18	lnc-SLC16A1-1	chr1:113362878-113363160	XLOC_000966
19	lnc-SLC16A1-1	chr1:113355832-113357984	ucscGeneNc_uc001ede_1
20	lnc-SLC16A1-1	chr1:113368135-113368294	NONHSAT005284
21	lnc-FAM19A3-6	chr1:113377818-113377983	NONHSAT005288
22	lnc-SLC16A1-1	chr1:113368135-113368294	XLOC_000966
23	lnc-SLC16A1-1	chr1:113371099-113371133	XLOC_000966
24	lnc-SLC16A1-1	chr1:113362912-113363160	ENSG00000215866.3
25	lnc-SLC16A1-1	chr1:113366275-113366376	XLOC_000966
26	lnc-SLC16A1-1	chr1:113366275-113366376	NONHSAT005284
27	lnc-FAM19A3-6	chr1:113352399-113352505	NONHSAT005281
28	lnc-SLC16A1-1	chr1:113362791-113363163	NONHSAT005284
29	lnc-SLC16A1-1	chr1:113383110-113383202	XLOC_000966
30	lnc-SLC16A1-1	chr1:113368135-113368294	ENSG00000215866.3
31	lnc-SLC16A1-1	chr1:113362796-113363163	XLOC_000966

No data

Variant related genes	Relation type
ENSG00000155380	chromatin interactions
ENSG00000261595	chromatin interactions
ENSG00000184599	chromatin interactions
ENSG00000198799	chromatin interactions
ENSG00000155367	chromatin interactions
ENSG00000238198	chromatin interactions
ENSG00000215866	chromatin interactions
NEK6	miRNA target sites
TUBB6	miRNA target sites
SLC7A1	miRNA target sites
NCOA7	miRNA target sites
CREB3L2	miRNA target sites
PPIF	miRNA target sites
NCOR1	miRNA target sites
CREB5	miRNA target sites
NCOR2	miRNA target sites
NR4A3	miRNA target sites

Extended variants
information (count: 3018 )
Associated
traits (count: 102 )

Variant overlapped rSNPs/rCNVs (count:3018 , 50 per page) page: 1 2 3 4 5 6 7 ... 61

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs11590090	chr1:113313563-113313564	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance disease
2	rs7548442	chr1:113313583-113313584	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
3	rs536979155	chr1:113313638-113313639	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
4	rs553368845	chr1:113313672-113313673	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
5	rs76480921	chr1:113313755-113313756	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
6	rs539083291	chr1:113313793-113313794	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
7	rs558774304	chr1:113313814-113313815	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
8	rs575741925	chr1:113313837-113313838	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
9	rs544056871	chr1:113313838-113313839	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
10	rs72990325	chr1:113313842-113313843	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
11	rs565955347	chr1:113313903-113313904	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
12	rs114601705	chr1:113313904-113313905	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
13	rs574357933	chr1:113313909-113313910	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
14	rs376231972	chr1:113313977-113313978	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
15	rs540160412	chr1:113313999-113314000	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
16	rs370315986	chr1:113314013-113314014	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
17	rs529402739	chr1:113314026-113314027	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
18	rs546650788	chr1:113314165-113314166	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
19	rs559674947	chr1:113314178-113314179	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
20	rs532017955	chr1:113314181-113314182	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
21	rs76725688	chr1:113314182-113314183	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
22	rs562438732	chr1:113314206-113314207	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs531461619	chr1:113314223-113314224	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs190249944	chr1:113314231-113314232	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs567873862	chr1:113314317-113314318	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs530389874	chr1:113314359-113314360	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs547327348	chr1:113314527-113314528	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs567212582	chr1:113314541-113314542	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs145376182	chr1:113314554-113314555	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs558939461	chr1:113314558-113314559	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs374609397	chr1:113314579-113314580	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs528385068	chr1:113314667-113314668	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs6699164	chr1:113314676-113314677	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
34	rs182548177	chr1:113314702-113314703	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs147660823	chr1:113314726-113314727	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs142454061	chr1:113314729-113314730	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs186827999	chr1:113314733-113314734	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs200535922	chr1:113314787-113314788	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs12074039	chr1:113314789-113314790	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs193173042	chr1:113314826-113314827	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs371092694	chr1:113314843-113314844	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs545457919	chr1:113314892-113314893	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs78524935	chr1:113314898-113314899	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs567929556	chr1:113314912-113314913	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs9659014	chr1:113314963-113314964	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
46	rs185116104	chr1:113314970-113314971	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs541968429	chr1:113314992-113314993	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs113800712	chr1:113315000-113315001	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs530307715	chr1:113315021-113315022	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs543687165	chr1:113315183-113315184	Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:102)

Disease	PMID	Source
Wilms tumour	21544195	CNVD
Coronary Disease	20032323	CNVD
Prostate cancer	21965145	CNVD
Glioblastoma multiforme	21080181	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Stargardt''s disease	17277736	CNVD
Neuroblastoma	17897457	CNVD
Uveal melanoma	21693616	CNVD
Cancer	21637783	CNVD
Colorectal cancer	20709793	CNVD
Ewing''s sarcoma	21437220	CNVD
Neuroblastoma	21484798	CNVD
Non-syndromic sensorineural hearing loss	22290220	CNVD
Liposarcoma	21253554	CNVD
Breast cancer	21264507	CNVD
Acute myeloid leukemia	16864856	CNVD
Astrocytoma	17387387	CNVD
Cancer	21499728	CNVD
Glioblastoma multiforme	17387387	CNVD
Oligodendroglial tumors	17285580	CNVD
Papillary thyroid carcinoma	21436994	CNVD
Neuroblastoma	17535989	CNVD
Pheochromocytoma	17535989	CNVD
Prostate cancer	16705090	CNVD
Astrocytoma	17934521	CNVD
Colorectal cancer	19359472	CNVD
Neuroblastoma	18664255	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Multiple myeloma	17077331	CNVD
Gastrointestinal stromal cancer	19259404	CNVD
Gastrointestinal stromal cancer	20470368	CNVD
Gastrointestinal stromal cancer	17535989	CNVD
Neuroblastoma	17533364	CNVD
Paraganglioma	17535989	CNVD
Pulmonary chondroma	17535989	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Breast cancer	17603634	CNVD
Esophageal squamous carcinoma	21637470	CNVD
HIV/AIDS	22032296	CNVD
Schizophrenia	19415332	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
Thoracic aortic aneurysm	21092924	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Autism	22495311	CNVD
Non-small cell lung cancer	21385341	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Chordoma	21602918	CNVD
Acute lymphoblastic leukemia	17443227	CNVD
Melanoma	18172304	CNVD
Multiple myeloma	16461302	CNVD
Cancer	21129771	CNVD
Autosomal dominant nocturnal frontal lobe epilepsy	18472482	CNVD
Hirschsprung''s Disease	21712996	CNVD
Non-small cell lung cancer	20864512	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Thrombocytopenia-absent radius syndrome	21933853	CNVD
Psychiatric disorder	22848183	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Hepatocellular carcinoma	16750200	CNVD
Burkitt''s lymphoma	18698080	CNVD
Breast cancer	20409316	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Breast cancer	17393978	CNVD
Medulloblastoma	21979893	CNVD
Cervical cancer	21062161	CNVD
Cancer	21183584	CNVD
Lung cancer	18438408	CNVD
Breast cancer	21364760	CNVD
Rett syndrome	21593744	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Ovarian cancer	21720365	CNVD
Intellectual disability	22102821	CNVD
Cancer	20164919	CNVD
Malignant mesothelioma	18160781	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Pancreatic endocrine tumor	17639061	CNVD
small cell lung cancer	20016488	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Multiple myeloma	17550852	CNVD
Gastrointestinal stromal cancer	20818650	CNVD
Asthma	20841430	CNVD
Aetanephric adenomas	20802469	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Multiple myeloma	16616336	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Systemic lupus erythematosus	21956041	CNVD
Cancer	20164920	CNVD
Myelofibrosis	22110671	CNVD
Gastric adenocarcinoma	19115996	CNVD
Ovarian neoplasms	16753589	CNVD
Prostate cancer	16573809	CNVD
Glioma	17123091	CNVD
Lung cancer	16773561	CNVD
Breast cancer	17899364	CNVD
Cutaneous malignant melanoma	17690212	CNVD
Melanoma	19671679	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Bipolar disorder	19114987	CNVD
Schizophrenia	23813976	CNVD
Pancreatic cancer	17952125	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD

Chromatin state (count:972 , 50 per page) page: 1 2 3 4 5 6 7 ... 20

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr1:113305600-113320000	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
2	chr1:113305600-113332800	Weak transcription	H9 Cell Line	embryonic stem cell
3	chr1:113307400-113316000	Weak transcription	Breast Myoepithelial Primary Cells	Breast
4	chr1:113308800-113313600	Weak transcription	iPS-15b Cell Line	embryonic stem cell
5	chr1:113310600-113320800	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
6	chr1:113312400-113313600	Enhancers	GM12878-XiMat	blood
7	chr1:113312400-113313800	Weak transcription	iPS-18 Cell Line	embryonic stem cell
8	chr1:113313000-113313800	Enhancers	Primary T helper memory cells from peripheral blood 2	blood
9	chr1:113313000-113314400	Enhancers	Stomach Mucosa	stomach
10	chr1:113313200-113314000	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
11	chr1:113313400-113313800	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Male	--
12	chr1:113313400-113314200	Enhancers	ES-I3 Cell Line	embryonic stem cell
13	chr1:113313400-113314200	Enhancers	H1 Cell Line	embryonic stem cell
14	chr1:113313600-113313800	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Female	--
15	chr1:113313600-113314200	Enhancers	HUES6 Cell Line	embryonic stem cell
16	chr1:113313600-113314200	Bivalent Enhancer	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
17	chr1:113313600-113314400	Enhancers	iPS-15b Cell Line	embryonic stem cell
18	chr1:113313800-113314200	Bivalent Enhancer	Primary mononuclear cells fromperipheralblood	Blood
19	chr1:113313800-113314200	Enhancers	Duodenum Mucosa	Duodenum
20	chr1:113313800-113314400	Enhancers	iPS-18 Cell Line	embryonic stem cell
21	chr1:113314200-113315600	Weak transcription	ES-I3 Cell Line	embryonic stem cell
22	chr1:113315400-113316000	ZNF genes & repeats	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
23	chr1:113315600-113315800	Active TSS	ES-I3 Cell Line	embryonic stem cell
24	chr1:113316000-113317800	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
25	chr1:113317800-113318400	ZNF genes & repeats	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
26	chr1:113318800-113319400	Enhancers	Fetal Brain Male	brain
27	chr1:113320800-113321200	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
28	chr1:113321000-113321200	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
29	chr1:113321200-113334600	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
30	chr1:113321800-113322000	Weak transcription	Aorta	Aorta
31	chr1:113322600-113322800	Enhancers	H1 Cell Line	embryonic stem cell
32	chr1:113322600-113323000	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
33	chr1:113322800-113323000	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin02	Skin
34	chr1:113322800-113325000	Weak transcription	H1 Cell Line	embryonic stem cell
35	chr1:113325600-113350800	Weak transcription	Breast Myoepithelial Primary Cells	Breast
36	chr1:113331000-113331800	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
37	chr1:113331400-113331800	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
38	chr1:113331400-113332200	Enhancers	Fetal Adrenal Gland	Adrenal Gland
39	chr1:113331600-113332000	Enhancers	Foreskin Melanocyte Primary Cells skin01	Skin
40	chr1:113332000-113333000	Weak transcription	Foreskin Melanocyte Primary Cells skin01	Skin
41	chr1:113332200-113332600	Weak transcription	Fetal Adrenal Gland	Adrenal Gland
42	chr1:113332600-113334200	Enhancers	Cortex derived primary cultured neurospheres	brain
43	chr1:113332600-113337600	Enhancers	Fetal Adrenal Gland	Adrenal Gland
44	chr1:113332800-113333200	Bivalent Enhancer	H9 Cell Line	embryonic stem cell
45	chr1:113332800-113333200	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
46	chr1:113332800-113334800	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
47	chr1:113332800-113335000	Enhancers	K562	blood
48	chr1:113333000-113333200	Enhancers	Foreskin Melanocyte Primary Cells skin01	Skin
49	chr1:113333000-113334200	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
50	chr1:113333000-113334600	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links